Invacare Corporation to Participate at March Conferences
Invacare Corporation (NYSE: IVC) announced its conference schedule for March 2021, participating in key healthcare events. On March 16, the company will be part of the Morgan Stanley Virtual Healthcare Corporate Access Day and at 3:10 p.m. ET, CEO Matt Monaghan will present at the Oppenheimer 31st Annual Healthcare Conference, with a webcast available for 90 days. On March 23, he will also engage in a fireside chat at the KeyBanc Life Sciences & MedTech Investor Forum. Management will be available for one-on-one meetings with investors.
- None.
- None.
Invacare Corporation (NYSE: IVC) a leading manufacturer and distributor of medical equipment used in non-acute care settings, announces its conference schedule for March 2021:
- Tuesday, March 16, the Company will participate in the Morgan Stanley Virtual Healthcare Corporate Access Day.
- Tuesday, March 16, at 3:10 p.m. ET, Matt Monaghan, chairman, president, and chief executive officer will present at the Oppenheimer 31st Annual Healthcare Conference. The live webcast of the presentation will be available at https://wsw.com/webcast/oppenheimer9/ivc/2491786 and it will be accessible for replay for 90 days following the conference.
- Tuesday, March 23, at 1:15 p.m. ET, Matt Monaghan will participate in a fireside chat at the KeyBanc Life Sciences & MedTech Investor Forum. The live webcast of the presentation will be available at https://wsw.com/webcast/key15/ivc/1535870 and it will be accessible for replay for 90 days following the conference.
The company’s management team, including Mr. Monaghan; Kathy Leneghan, senior vice president and chief financial officer; and Lois Lee, director of treasury, investor relations and corporate communications, will be available for 1x1 meetings at all events with interested investors.
A copy of the updated IR presentation will be posted on the Company’s website at www.invacare.com/investorrelations.
About Invacare Corporation
Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers. The company sells its products principally to home medical equipment providers with retail and e-commerce channels, residential care operators, distributors and government health services in North America, Europe and Asia/Pacific. For more information about the company and its products, visit Invacare's website at www.invacare.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210302006145/en/
FAQ
What is Invacare Corporation's conference schedule for March 2021?
When will Matt Monaghan present at the Oppenheimer Conference?
Will the presentations be available for replay?
Where can I find the updated investor relations presentation for Invacare?